Lipophilic prodrug of paclitaxel: Interaction with a dimyristoylphosphatidylcholine monolayer

International Journal of Pharmaceutics

Volumn 475, Issue 1, 2014, Pages 624-631

  Giuffrida, Maria Chiara ^a   Dosio, Franco ^b   Castelli, Francesco ^c   Sarpietro, Maria Grazia ^c  

^a Interuniversity Consortium INBB   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Dimyristoylphosphatidylcholine monolayer; Langmuir Blodgett; Lipophilic prodrug; Paclitaxel

Indexed keywords

1,1,2 TRISNORSQUALENOIC ACID; ACID; DIMYRISTOYLPHOSPHATIDYLCHOLINE; PACLITAXEL; PRODRUG; SQUALENE DERIVATIVE; SQUALENOYL PRODRUG; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; LIPOSOME; SQUALENE;

ARTICLE; COMPRESSIBILITY MODULUS; COMPRESSION; CONTROLLED STUDY; DRUG CONJUGATION; ENERGY; GIBBS FREE ENERGY; ISOTHERM; LANGMUIR BLODGETT FILM; LIPID MONOLAYER; LIPOPHILICITY; MISCIBILITY; MIXED MONOLAYER ISOTHERM; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; SYNTHESIS; THERMODYNAMICS; ANALOGS AND DERIVATIVES; CHEMISTRY; MEDICINAL CHEMISTRY; PROCEDURES;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPOSOMES; PACLITAXEL; PRODRUGS; SQUALENE;

EID: 84908143938     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.09.022     Document Type: Article

References (43)

1. O.H. Alkan, S. Ramakrishnan, H.B. Chai, and J.M. Pezzuto A mixed micellar formulation suitable for the parenteral administration of taxol Pharm. Res. 11 1994 206 212
2. S.V. Balasubramanian, and R.M. Straubinger Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes Biochemistry 33 1994 8941 8947
3. C. Ballatore, K.R. Brunden, D.M. Huryn, J.Q. Trojanowski, V.M.-Y. Lee, and A.B. Smith Microtubule stabilizing agents as potential treatment for alzheimer's disease and related neurodegenerative tauopathies J. Med. Chem. 55 2012 8979 8996
4. G.L. Biagi, M.C. Guerra, and A.M. Barbaro Relation between lipophilic character and hemolytic activity of testosterone and testosterone esters J. Med. Chem. 13 1970 944 948
5. H. Burt, X. Zhang, P. Toleikis, L. Embree, and W. Hunter Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel Colloids Surf. B 16 1999 161 171
6. F. Castelli, M.G. Sarpietro, D. Miceli, B. Stella, F. Rocco, and L. Cattel Enhancement of gemcitabine affinity for biomembranes by conjugation with squalene: differential scanning calorimetry and Langmuir-Blodgett studies using biomembrane models J. Colloid Interface Sci. 316 2007 43 52
7. F. Castelli, M.G. Sarpietro, F. Rocco, M. Ceruti, and L. Cattel Interaction of lipophilic gemcitabine prodrugs with biomembranes models studied by Lagmuir-Blodgett technique J. Colloid Interface Sci. 313 2007 363 368
8. G. Chimote, and R. Banerjee Molecular interactions of cord factor with dipalmitoylphosphatidylcholine monolayers: implications for lung surfactant dysfunction in pulmonary tuberculosis Colloids Surf. B 65 2008 120 125
9. T.H. Chou, and C.H. Chang Thermodynamic characteristics of mixed DPPC/DHDP monolayers on water and phosphate buffer subphases Langmuir 16 2000 3385 3390
10. P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio, and L. Cattel Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes J. Control. Release 63 2000 19 30
11. J. Crown, and M. O'Leary The taxanes: an update Lancet 355 2000 1176 1178
12. G. Das, G. Rao, R. Wilson, and T. Chandy Controlled delivery of taxol from poly(ethylene glycol)-coated poly(lactic acid) microsphere J. Biomed. Mater. Res. 55 2001 96 103
13. J.T. Davies, and E.K. Rideal Interfacial Phenomena 1963 Academic Press New York
14. J.F. Díaz, I. Barasoain, and J.M. Andreu Fast kinetics of taxol binding to microtubules J. Biol. Chem. 278 2003 8407 8419
15. E.A. Eisenhauer, and J.B. Vermorken The taxoids: comparative clinical pharmacology and therapeutic potential Drugs 55 1998 5 30
16. S. Feng, and G. Huang Effects of emulsifiers on the controlled release of paclitaxel (taxol) from nanospheres of biodegradable polymers J. Control. Release 71 2001 53 69
17. M.L. Fjallskog, L. Frii, and J. Bergh Is Cremophor, a solvent for paclitaxel, cytotoxic? Lancet 1993 342 876
18. G.L. Gaines Insoluble Monolayers at Liquid-Gas Interfaces 1966 Wiley-Interscience New York
19. H. Gylling, and T.A. Miettinen Post absorptive metabolism of dietary squalene Atherosclerosis 106 1994 169 178
20. B. Gzyl-Malcher, M. Filek, and G. Brezesinski Mixed DPPC/DPTAP monolayers at the air/water interface: influence of indolilo-3-acetic acid and selenate ions on the monolayer morphology Langmuir 27 2011 10886 10893
21. K. Hac-Wydro, and P. Wydro The influence of fatty acids on model cholesterol/phospholipid membranes Chem. Phys. Lipids 150 2007 66 81 http://www.vcclab.org/lab/alogps/start.html
22. T. Kamilya, P. Pal, and G.B. Talapatra Interaction of ovalbumin with phospholipids Langmuir-Blodgett film J. Phys. Chem. B 111 2007 1199 1205
23. P. Kan, Z. Chen, C. Lee, and I. Chu Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system J. Control. Release 58 1999 271 278
24. S.Y. Kim, D.H. Kim, H.J. Lee, Y.J. Seo, J.H. Lee, and Y. Lee Treatment of disseminated classic type of Kaposi's sarcoma with paclitaxel Ann. Dermatol. 23 2011 504 507
25. P.V.I. Koivisto, and T.A. Miettinen Increased amount of cholesterol precursors in lipoproteins after ileal exclusion Lipids 23 1998 993 996
26. M. Li, S. Su, M. Xin, and Y. Liao Relationship between N,N-dialkyl chitosan monolayer and corresponding vesicle J. Colloid Interface Sci. 311 2007 285 288
27. T.A. Miettinen, and H. Vanhanen Serum concentration and metabolism of cholesterol during rapeseed oil and squalene feeding Am. J. Clin. Nutr. 59 1994 356 363
28. E. Nogales, S.G. Wolf, and K.H. Downing Structure of the β-tubulin dimer by electron crystallography Nature 391 1998 199 203
29. R. Panchagnula Pharmaceutical aspects of paclitaxel Int. J. Pharm. 172 1998 1 15
30. L. Prince, and D.F. Sears Biological Horizons in Surface Science 2012 Academic Press, Inc. New York
31. M.G. Sarpietro, S. Ottimo, M.C. Giuffrida, F. Rocco, M. Ceruti, and F. Castelli Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers Int. J. Pharm 406 2011 69 77
32. M.G. Sarpietro, S. Ottimo, D. Paolino, A. Ferrero, F. Dosio, and F. Castelli Squalenoyl prodrug of paclitaxel: synthesis and evaluation of its incorporation in phospholipid bilayers Int. J. Pharm. 436 2012 135 140
33. M.W. Saville, J. Lietzau, J.M. Pluda, I. Feuerstein, J. Odom, W.H. Wilson, R.W. Humphrey, E. Feigal, S.M. Steinberg, and S. Broder Treatment of HIV-associated Kaposi's sarcoma with paclitaxel Lancet 346 1995 26 28
34. P.B. Schiff, J. Fant, and S.B. Horwitz Promotion of microtubule assembly in vitro by taxol Nature 277 1979 665 667
35. D. Sharma, T.P. Chelvi, J. Kaur, and R. Ralhan Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma Melanoma Res. 8 1998 240 244
36. M.F. Shieh, I.M. Chu, C.J. Lee, P. Kan, D.M. Hau, and J.J. Shieh Liposomal delivery system for taxol J. Ferment. Bioeng. 83 1997 87 90
37. U.S. Shrama, S.V. Balasubramanian, and R.M. Staubinger Pharmaceutical and physical properties of paclitaxel (taxol) complexes with cyclodextrins J. Pharm. Sci. 84 1995 1223 1230
38. M.E. Stewart Sebaceous gland lipids Semin. Dermatol. 11 1992 100 105
39. E.E. Van Tamelen Bioorganic chemistry: sterols and acyclic terpene terminal epoxides Acc. Chem. Res. 1 1968 111 120
40. M.C. Wani, H.L. Taylor, M.E. Wall, P. Coggon, and A.T. McPhail Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia J. Am. Chem. Soc. 93 1971 2325 23627
41. L. Welles, M.W. Saville, J. Lietzau, J.M. Pluda, K.M. Wyvill, I. Feuerstein, W.D. Figg, R. Lush, J. Odom, W.H. Wilson, M.T. Fajardo, R.W. Humphrey, E. Feigal, D. Tuck, S.M. Steinberg, S. Broder, and R. Yarchoan Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma J. Clin. Oncol. 16 1998 1112 1121
42. C.-Y. Wu, C.-Y. Chang, H.-H. Ma, C.-W. Wang, Y.-T. Chen, P.-W. Hsiao, C.-C. Chang, C.-H. Chan, C.-C. Liu, and J.-R. Chen Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses Vaccine 32 2014 4485 4494
43. L. Zhao, and S.-S. Feng Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes J. Colloid Interface Sci. 274 2004 55 68